Dear colleagues,
I’m delighted to share with you Cancer Frontline from The University of Texas MD Anderson Cancer Center.
As our allies in the fight to eliminate cancer, we want you to be in the know about the latest research, discoveries and advances as they happen at MD Anderson. Cancer Frontline will keep you informed of our work, recognize the significant efforts of our partners and, hopefully, inspire new collaborations...
How can technological innovation help end cancer?
That's the question IBM and MD Anderson Cancer Center recently posed when they teamed...
An MD Anderson researcher has been awarded for his work leading to an entirely new way to treat cancer.
James Allison, Ph.D., chair...
Researchers from the MD Anderson Cancer Center found that 93% of head and neck cancer patients treated with multi-field optimization intensity modulated proton therapy (MFO-IMPT) were cancer-free 28 months after treatment. Side effects typical of standard radiation also were reduced in some cases.
“Though early, this study provides the first evidence that proton therapy for head and neck cancers, which are becoming increasingly...
Collaborations are crucial to making significant advancements toward ending cancer. Creating a worldwide network of basic, translational,...
MD Anderson Cancer Center is expanding its efforts to combat lung cancer and other diseases. And an important piece of this initiative will...
The following opinion piece includes the collective thoughts of several MD Anderson prevention researchers
Recently, the Food and Drug...
The G.H.A. Clowes Memorial Award is the oldest honor bestowed on a researcher by the American Association for Cancer Research. It's been given...
The promise of immunotherapy, drugs that stimulate the body's immune system to fight cancer, can be witnessed by observing the string of development...
Additional presentations of note at this year's American Association for Cancer Research Annual Meeting:
Reclassifying low-grade brain...